Investigation of the impact of sarizotan on the pharmacokinetics of levodopa
✍ Scribed by Sonja Krösser; Roland Neugebauer; Didier Chassard; Andreas Kovar
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 133 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0142-2782
- DOI
- 10.1002/bdd.558
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The aim of our study was to evaluate the influence of low-intensity exercise on levodopa absorption and levodopa motor effect. We studied the pharmacokinetics and pharmacodynamics of levodopa under resting conditions and under a workload of 50 watts for 2 hours on a cycle ergometer in 12 parkinsonia
## Abstract Dyskinesias are a major complication of dopaminergic therapy in the long‐term treatment of Parkinson's disease. In the CALM‐PD trial, subjects were initially randomized to levodopa or pramipexole and could later add levodopa if needed. After adjusting for disease duration and daily levo